alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 20.104 Summaries of oral discussions. ( a ) All written summaries of oral discussions, whether in person or by telephone, with members of the public, members of Congress, organization or company officials, or other persons, except members of the Executive Branch of the Federal government or special government employees, are available for public disclosure.
( b ) Any such summary is available for public disclosure at the time that it is prepared by the Food and Drug Administration unless a different time for such disclosure is specified in other rules established or cross-referenced in this part, e.g., summaries of oral discussions relating to a food additive petition in § 171.1(h)(3) of this chapter.
( c ) If more than one summary of an oral discussion exists in a Food and Drug Administration file, all such summaries shall be disclosed in response to any request for such summary.
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1676 Pyridoxine hydrochloride. ( a ) Pyridoxine hydrochloride (C8H11NO3·HCl, CAS Reg. No. 58-56-0) is the chemical 3-hydroxy-4,5-dihydroxymethy-2-methylpyridine hydrochloride that is prepared by chemical synthesis.
( b ) The ingredient meets the specifications of the Food Chemicals Codex, 3d Ed. (1981), p. 260, which is incorporated by reference. Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as a nutrient supplement as defined in § 170.3(o)(20) of this chapter.
( 2 ) The ingredient is used in the following foods at levels not to exceed current good manufacturing practice: baked goods as defined in § 170.3(n)(1) of this chapter; nonalcoholic beverages and beverage bases as defined in § 170.3(n)(3) of this chapter; breakfast cereals as defined in § 170.3(n)(4) of this chapter; dairy product analogs as defined in § 170.3(n)(10) of this chapter; meat products as defined in § 170.3(n)(29) of this chapter; milk products as defined in § 170.3(n)(31) of this chapter; plant protein products as defined in § 170.3(n)(33) of this chapter; and snack foods as defined in § 170.3(n)(37) of this chapter. Pyridoxine hydrochloride may be used in infant formula in accordance with section 412(g) of the Federal Food, Drug, and Cosmetic Act (the Act) or with regulations promulgated under section 412(a)(2) of the Act.
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[48 FR 51615, Nov. 10, 1983]
§ 182.1711 Silica aerogel. ( a ) *Product.* Silica aerogel as a finely powdered microcellular silica foam having a minimum silica content of 89.5 percent.
( b ) [Reserved]
( c ) *Limitations, restrictions, or explanation.* This substance is generally recognized as safe when used as a component of an anti-foaming agent in accordance with good manufacturing practice.
Editorial Note on Part 170
Editorial Note: Nomenclature changes to part 170 appear at 66 FR 56035, Nov. 6, 2001, and 69 FR 13717, Mar. 24, 2004.

§ 170.235 Part 3 of a GRAS notice: Dietary exposure. In part 3 of your GRAS notice, you must provide data and information about dietary exposure (*i.e.,* the amount of relevant substances that consumers are likely to eat or drink as part of a total diet), regardless of whether your conclusion of GRAS status is through scientific procedures or through experience based on common use in food, as follows: ( a ) You must provide an estimate of dietary exposure to the notified substance that includes exposure from its intended use and all sources in the diet; and
( b ) When applicable, you must provide an estimate of dietary exposure to any other substance that is expected to be formed in or on food because of the use of the notified substance (*e.g.,* hydrolytic products or reaction products);
( c ) When applicable, you must provide an estimate of dietary exposure to any other substance that is present with the notified substance either naturally or due to its manufacture (*e.g.,* contaminants or by-products);
( d ) You must describe the source of any food consumption data that you use to estimate dietary exposure in accordance with paragraphs (a) through (c) of this section; and
( e ) You must explain any assumptions you made to estimate dietary exposure in accordance with paragraphs (a) through (c) of this section.
§ 1141.5 Incorporation by reference. ( a ) Certain material is incorporated by reference into this part with the approval of the Director of the Federal Register under 5 U.S.C. 552(a) and 1 CFR part 51. All approved material is available for inspection at U.S. Food and Drug Administration, Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, and is available from the source listed in paragraph (b) of this section. It is also available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, email *fedreg.legal@nara.gov* or go to *www.archives.gov/federal-register/cfr/ibr-locations.html .*
( b ) Center for Tobacco Products, U.S. Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993; 1-888-463-6332. You may also obtain the material at *https://www.fda.gov/cigarette-warning-files .* ( 1 ) “Required Cigarette Health Warnings, 2020”, IBR approved for § 1141.10.
( 2 ) [Reserved]
EXHIBIT 32.1
**WFS FINANCIAL INC**
CERTIFICATION OF CEO
In connection with the Annual Report of WFS Financial Inc (the “Company”) on Form 10-K for theperiod ending December 31, 2004 as filed with the Securities and Exchange Commission on the datehereof (the “Report”), the undersigned Chief Executive Officer of the Company, hereby certifies,to the best of his knowledge and belief and pursuant to 18 U.S.C., Chapter 63, Section 1350, asadopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that:
 (1)  The Report fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities and Exchange Act of 1934; and  (2)  The information contained in the Report fairly presents, in all materialrespects, the financial condition and result of operations of the Company.
The foregoing Certification is furnished solely for purposes of complying with the provisions ofSection 906 of the Sarbanes-Oxley Act and is not intended to be used for any other purpose.
**WFS FINANCIAL INC**   /s/ Thomas A. WolfeThomas A. WolfePresident and ChiefExecutive Officer  
Date: March 11, 2005
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1298 Ferric citrate. ( a ) Ferric citrate (iron (III) citrate, C6H5FeO7, CAS Reg. No. 2338-05-8) is prepared from reaction of citric acid with ferric hydroxide. It is a compound of indefinite ratio of citric acid and iron.
( b ) The ingredient must be of a purity suitable for its intended use.
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food as a nutrient supplement as defined in § 170.3(o)(20) of this chapter, with no limitation other than current good manufacturing practice. The ingredient may also be used in infant formula in accordance with section 412(g) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 350a(g)) or with regulations promulgated under section 412(a)(2) of the act (21 U.S.C. 350a(a)(2)).
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[53 FR 16865, May 12, 1988, as amended at 73 FR 8607, Feb. 14, 2008]
[No. 37637-3-I.

Division One.

January 26, 1998.]

#### Barbara J. O’Steen, et al., *Respondents,*v. Betty J. Visser, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 94-2-05716-2, James Dore, J. Pro Tern., entered September 13, 1995. *Affirmed*by unpublished per curiam opinion.
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

JAMES R. GOODMAN,

Appellant,

v.

PALADIN FUND II, LLC,

Appellee.

No. 4D17-2084

[February 8, 2018]

Appeal from the Circuit Court for the Nineteenth Judicial Circuit, St. 

Lucie County; Robert E. Belanger, Judge; L.T. Case No. 562011-CA003406.

Stephen C. Breuer of Moffa & Breuer, PLLC, Plantation, for appellant.

Avri Ben-Hamo of Greenfield Law Group, P.A., Boca Raton, for appellee.

PER CURIAM.

Affirmed.

WARNER, MAY and DAMOORGIAN, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
UNITED STATES COURT OF APPEALS

FOR THE THIRD CIRCUIT

____________

No. 13-1247

_____________

UNITED INDUSTRIAL, SERVICE, TRANSPORTATION,

PROFESSIONAL AND GOVERNMENT WORKERS

OF NORTH AMERICA SEAFARERS INTERNATIONAL 

UNION, ON BEHALF OF ERNEST BASON,

 

Petitioner

v.

GOVERNMENT OF THE VIRGIN ISLANDS 

_______________

On Writ of Certiorari to the Supreme Court

of the Virgin Islands

(V.I. S. Ct. Civ. No.: 2011-0115)

_______________

Argued December 10, 2013

BEFORE: FISHER, COWEN AND NYGAARD, Circuit Judges

_______________

ORDER AMENDING OPINION

_______________

IT IS HEREBY ORDERED that the opinion in the above case, filed March 19, 

2014, be amended as follows:

Page 14, the sentence that read:

It notified this Court “that on or about April 4, 2012 nominal appellant Attorney Ernest 

Bason passed away.” (Suggestion of Death at 1.)
shall read:

It notified this Court “that on or about September 3, 2013 nominal appellant Attorney 

Ernest Bason passed away.” (Suggestion of Death at 1.)

BY THE COURT,

s/ Robert S. Cowen

Circuit Judge

Dated: March 21, 2014
# L_2019079EN.01001601.xml

| 21.3.2019 | EN | Official Journal of the European Union | L 79/16 |
| --- | --- | --- | --- |

21.3.2019

EN

Official Journal of the European Union

L 79/16

---

COUNCIL DECISION (EU) 2019/457

of 19 March 2019

appointing a member, proposed by the Kingdom of Spain, of the Committee of the Regions

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 305 thereof,

Having regard to the proposal of the Spanish Government,

Whereas:

| (1) | On 26 January 2015, 5 February 2015 and 23 June 2015, the Council adopted Decisions (EU) 2015/116 (1), (EU) 2015/190 (2) and (EU) 2015/994 (3) appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2015 to 25 January 2020. |
| --- | --- |

(1)

On 26 January 2015, 5 February 2015 and 23 June 2015, the Council adopted Decisions (EU) 2015/116 (1), (EU) 2015/190 (2) and (EU) 2015/994 (3) appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2015 to 25 January 2020.

| (2) | A member's seat on the Committee of the Regions has become vacant following the end of the term of office of Ms Susana DÍAZ PACHECO, |
| --- | --- |

(2)

A member's seat on the Committee of the Regions has become vacant following the end of the term of office of Ms Susana DÍAZ PACHECO,

HAS ADOPTED THIS DECISION:

Article 1

The following is hereby appointed as a member of the Committee of the Regions for the remainder of the current term of office, which runs until 25 January 2020:

| — | Mr Juan Manuel MORENO BONILLA, Presidente de la Junta de Andalucía. |
| --- | --- |

—

Mr Juan Manuel MORENO BONILLA, Presidente de la Junta de Andalucía.

Article 2

This Decision shall enter into force on the date of its adoption.

Done at Brussels, 19 March 2019.

For the Council

The President

G. CIAMBA

---

(1)  Council Decision (EU) 2015/116 of 26 January 2015 appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2015 to 25 January 2020 (OJ L 20, 27.1.2015, p. 42).

1

(2)  Council Decision (EU) 2015/190 of 5 February 2015 appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2015 to 25 January 2020 (OJ L 31, 7.2.2015, p. 25).

2

(3)  Council Decision (EU) 2015/994 of 23 June 2015 appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2015 to 25 January 2020 (OJ L 159, 25.6.2015, p. 70).

3

---
Editorial Note on Part 130
Editorial Note: Nomenclature changes to part 130 appear at 81 FR 49896, July 29, 2016.

§ 130.3 Definitions and interpretations. ( a ) The definitions and interpretations of terms contained in section 201 of the act shall be applicable also to such terms when used in regulations promulgated under the act.
( b ) If a regulation prescribing a definition and standard of identity for a food has been promulgated under section 401 of the act and the name therein specified for the food is used in any other regulation under section 401 or any other provision of the act, such name means the food which conforms to such definition and standard, except as otherwise specifically provided in such other regulation.
( c ) No provision of any regulation prescribing a definition and standard of identity or standard of quality or fill of container under section 401 of the act shall be construed as in any way affecting the concurrent applicability of the general provisions of the act and the regulations thereunder relating to adulteration and misbranding. For example, all regulations under section 401 contemplate that the food and all articles used as components or ingredients thereof shall not be poisonous or deleterious and shall be clean, sound, and fit for food. A provision in such regulations for the use of coloring or flavoring does not authorize such use under circumstances or in a manner whereby damage or inferiority is concealed or whereby the food is made to appear better or of greater value than it is.
( d ) *Safe and suitable* means that the ingredient: ( 1 ) Performs an appropriate function in the food in which it is used.
( 2 ) Is used at a level no higher than necessary to achieve its intended purpose in that food.
( 3 ) Is not a food additive or color additive as defined in section 201 (s) or (t) of the Federal Food, Drug, and Cosmetic Act as used in that food, or is a food additive or color additive as so defined and is used in conformity with regulations established pursuant to section 409 or 721 of the act.
( e ) Section 403(i) of the act requires the listing of all ingredients in standardized foods. All ingredients must be listed in accordance with the requirements of part 101 of this chapter, except that where a definition and standard of identity has specific labeling provisions for optional ingredients, optional ingredients may be declared in accordance with those provisions.
[42 FR 14357, Mar. 15, 1977, as amended at 58 FR 2876, Jan. 6, 1993]
### Bedrock geologic and joint trend map of the Pinardville quadrangle, Hillsborough County, New Hampshire

By: William C. Burton**Thomas R. Armstrong

                            https://doi.org/10.3133/ofr20131027

#### Links

- More information:  **USGS Index Page**
- Plate:  **Ofr2013 1027**                            (pdf)
- Companion File:  **Companion Files**
- NGMDB Index Page:  **National Geologic Map Database Index Page**
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

#### Study Area

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
**Exhibit 32**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350AS ADOPTED****PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACTOF 2002**

 

The certifications set forth below are hereby submitted to theSecurities and Exchange Commission pursuant to, and solely for the purpose ofcomplying with, Section 1350 of Chapter 63 of Title 18 of the UnitedStates Code in connection with the filing on the date hereof with theSecurities and Exchange Commission of the Quarterly Report on Form 10-Q ofthe Company for the quarter ended June 30, 2008.

 

Each of the undersigned hereby certifies in his capacity as an officerof Citizens Bancshares Corporation and subsidiary (the “Company”) that, to hisknowledge on the date of this certification, the Quarterly Report of theCompany on Form 10-Q for the period ended June 30, 2008 fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934 and that the information contained in suchreport fairly presents, in all material respects, the financial condition ofthe Company at the end of such period and the results of operations of theCompany for such period.

 

 
| Date:  | August 14, 2008 | By:                                   | /s/ James E. Young |
|--------|----------------------|---------------------------------------|--------------------|
|   |                 | James E. Young                        |
|   |                 | President and Chief Executive Officer |
|   |                 |                                  |
|   |                 |                                  |
| Date:  | August 14, 2008 | By:                                   | /s/ Cynthia N. Day |
|   |                 | Cynthia N. Day                        |
|   |                 | Senior Executive Vice President and   |
|   |                 | Chief Operating Officer               |
|   |                 |                                  |
|   |                 |                                  |
| Date:  | August 14, 2008 | By:                                   | /s/ Samuel J. Cox  |
|   |                 | Samuel J. Cox                         |
|   |                 | Executive Vice President and          |
|   |                 | Chief Financial Officer               |

 

1

----
Exhibit
32





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED


PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





The
undersigned hereby certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the quarterly
report of United States Basketball League, Inc. on Form 10-Q for the quarterly
period ended May 31, 2010 fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934 and that the information
contained in such quarterly report on Form 10-Q fairly presents in all material
respects the financial condition and results of operation of United States
Basketball League, Inc.





Date:  July
20, 2010





/s/ Daniel T. Meisenheimer,
    IIIDaniel
      T. Meisenheimer, IIIPresident





Date:  July
20, 2010





/s/ Richard C.
  MeisenheimerRichard
      C. MeisenheimerChief
      Financial Officer
Exhibit 31.2

CERTIFICATION UNDER SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Steven M. Goldschein, Chief Financial Officer of Systemax Inc., certify
that:

1. I have reviewed this annual report on Form 10-K of Systemax
Inc. (the registrant);

2. Based on my knowledge, this annual report does not contain
any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by
this annual report;

3. Based on my knowledge, the financial statements, and other
financial information included in this annual report, fairly present in all
material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this annual
report;

4. The registrants other certifying officer and I are
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
and (except as disclosed in Item 9A of this annual report on Form 10-K) we
have:

a) designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to
reasonably ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within
these entities, particularly during the period in which this annual report is
being prepared;

b) evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

c) disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the
registrants fourth fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the registrants control over
financial reporting.

5. The registrants other certifying officer and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrants auditors and the audit committee
of the registrants board of directors:

a) all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting known to me
which are reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrants internal
controls over financial reporting.

Date: August 29, 2006

/s/ STEVEN M. GOLDSCHEIN
Steven M. Goldschein, Chief Financial Officer
###### Editorial Note on Part 178

#### Editorial Note:

Nomenclature changes to part 178 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

#### § 178.3125 Anticorrosive agents.

The substances listed in this section may be used as anticorrosive agents in food-contact materials subject to the provisions of this section:

| Substances | Limitations |
| --- | --- |
| Zinc hydroxy phosphite (CAS Reg. No. 55799-16-1) | For use only as a component of resinous and polymeric food-contact coatings intended for repeated use in contact with dry foods. |

[50 FR 21835, May 29, 1985]